Top Cost-Containment Stories
Group health care costs may soar 8.5% in 2026, PwC warns
By Allison BellThe firm sees the astonishingly high cost of "cellular, gene and RNA therapies" — high-tech treatments for conditions like sickle cell disease — as an emerging threat










